These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17050556)

  • 1. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking.
    Koch A; Gaczkowski M; Sturton G; Staib P; Schinköthe T; Klein E; Rubbert A; Bacon K; Wassermann K; Erdmann E
    Eur Respir J; 2007 Jan; 29(1):42-50. PubMed ID: 17050556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
    Glader P; von Wachenfeldt K; Löfdahl CG
    Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intraepithelial (CD103+) CD8+ T cells in the airways of smokers with and without chronic obstructive pulmonary disease.
    Mikko M; Forsslund H; Cui L; Grunewald J; Wheelock AM; Wahlström J; Sköld CM
    Immunobiology; 2013 Feb; 218(2):225-31. PubMed ID: 22652413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
    Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
    Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG
    Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
    Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
    Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.
    Paats MS; Bergen IM; Hoogsteden HC; van der Eerden MM; Hendriks RW
    Eur Respir J; 2012 Aug; 40(2):330-7. PubMed ID: 22183488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
    Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) Tc-lymphocytes immunodeviation in peripheral blood and airway from patients of chronic obstructive pulmonary disease and changes after short-term smoking cessation.
    Yu MQ; Liu XS; Wang JM; Xu YJ
    Chin Med J (Engl); 2013; 126(19):3608-15. PubMed ID: 24112150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease.
    Gupta J; Chattopadhaya D; Bhadoria DP; Qadar Pasha MA; Gupta VK; Kumar M; Dabur R; Yadav V; Sharma GL
    Clin Exp Immunol; 2007 Sep; 149(3):463-9. PubMed ID: 17565607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.
    Schild K; Knobloch J; Yakin Y; Jungck D; Urban K; Müller K; Koch A
    Int Immunopharmacol; 2011 Apr; 11(4):444-8. PubMed ID: 21215348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD.
    Siena L; Gjomarkaj M; Elliot J; Pace E; Bruno A; Baraldo S; Saetta M; Bonsignore MR; James A
    Respir Med; 2011 Oct; 105(10):1491-500. PubMed ID: 21612902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.
    de Boer WI; Sont JK; van Schadewijk A; Stolk J; van Krieken JH; Hiemstra PS
    J Pathol; 2000 Apr; 190(5):619-26. PubMed ID: 10727989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance between subpopulations of regulatory T cells in COPD.
    Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
    Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity.
    Freeman CM; Curtis JL; Chensue SW
    Am J Pathol; 2007 Sep; 171(3):767-76. PubMed ID: 17640964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease.
    Pons J; Sauleda J; Ferrer JM; Barceló B; Fuster A; Regueiro V; Julià MR; Agustí AG
    Eur Respir J; 2005 Mar; 25(3):441-6. PubMed ID: 15738286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.
    Saetta M; Mariani M; Panina-Bordignon P; Turato G; Buonsanti C; Baraldo S; Bellettato CM; Papi A; Corbetta L; Zuin R; Sinigaglia F; Fabbri LM
    Am J Respir Crit Care Med; 2002 May; 165(10):1404-9. PubMed ID: 12016104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.